BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aguado JM, Silva JT, Samanta P, Singh N. Tuberculosis and Transplantation. Microbiol Spectr. 2016;4. [PMID: 27809952 DOI: 10.1128/microbiolspec.tnmi7-0005-2016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Arron ST. Overview of Dermatological Diseases After Transplantation. Atlas of Dermatologic Diseases in Solid Organ Transplant Recipients 2022. [DOI: 10.1007/978-3-031-13335-0_2] [Reference Citation Analysis]
2 Lauar ID, Faria LC, Romanelli RMC, Clemente WT. Latent tuberculosis: Risk factors, screening and treatment in liver transplantation recipients from an endemic area. World J Transplant 2021; 11(12): 512-522 [DOI: 10.5500/wjt.v11.i12.512] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
3 Nasir N, Sarfaraz S, Khanum I, Ansari T, Nasim A, Dodani SK, Luxmi S. Tuberculosis in Solid Organ Transplantation: Insights from TB Endemic Areas. Curr Infect Dis Rep 2021;23. [DOI: 10.1007/s11908-021-00756-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Wang Y, Salvador NG, Lin C, Wu C, Lin T, Lee W, Chan Y, Chen C, Co JS, Encarnacion DD. Comparative analysis of the drug-drug interaction between immunosuppressants, safety and efficacy of rifabutin from rifampicin-based Anti-TB treatment in living donor liver transplant recipients with active tuberculosis. Biomedical Journal 2020. [DOI: 10.1016/j.bj.2020.08.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Di Dato F, Nunziata F, Rosa M, Iorio R, Spagnuolo MI. Tubercular hemoptysis in a young liver transplanted patient: Case report. Medicine (Baltimore) 2019;98:e16761. [PMID: 31415374 DOI: 10.1097/MD.0000000000016761] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Silva JT, San-Juan R, Fernández-Ruiz M, Aguado JM. Fluoroquinolones for the treatment of latent Mycobacterium tuberculosis infection in liver transplantation. World J Gastroenterol 2019; 25(26): 3291-3298 [PMID: 31341356 DOI: 10.3748/wjg.v25.i26.3291] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Salvador NGA, Wee SY, Lin CC, Wu CC, Lu HI, Lin TL, Lee WF, Chan YC, Lin LM, Chen CL. Clinical Outcomes of Tuberculosis in Recipients After Living Donor Liver Transplantation. Ann Transplant 2018;23:733-43. [PMID: 30337516 DOI: 10.12659/AOT.911034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
8 Zhong D, Liang SY. Approach to Transplant Infectious Diseases in the Emergency Department. Emerg Med Clin North Am 2018;36:811-22. [PMID: 30297006 DOI: 10.1016/j.emc.2018.06.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
9 Machuca I, Vidal E, de la Torre-cisneros J, Rivero-román A. Tuberculosis in immunosuppressed patients. Enfermedades infecciosas y microbiologia clinica (English ed ) 2018;36:366-374. [DOI: 10.1016/j.eimce.2018.04.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
10 Wu W, Yang M, Xu M, Ding C, Li Y, Xu K, Shen J, Li L. Diagnostic delay and mortality of active tuberculosis in patients after kidney transplantation in a tertiary care hospital in China. PLoS One 2018;13:e0195695. [PMID: 29659613 DOI: 10.1371/journal.pone.0195695] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]